Acquired and intrinsic resistance to vemurafenib in <scp> BRAF <sup>V600E</sup> </scp> ‐driven melanoma brain metastases
- DOI
- 10.1002/2211-5463.13730
- Published
- 2023-11-30
- Container
- FEBS Open Bio
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/2211-5463.13730,
title = {Acquired and intrinsic resistance to vemurafenib in
<scp>
BRAF
<sup>V600E</sup>
</scp>
‐driven melanoma brain metastases},
author = {Ping Zhang and Laura Esmee Kuil and Levi Conrad Maria Buil and Stephan Freriks and Jos Hendrik Beijnen and Olaf van Tellingen and Mark Cornelis de Gooijer},
year = {2023},
journal = {FEBS Open Bio},
doi = {10.1002/2211-5463.13730},
url = {https://doi.org/10.1002/2211-5463.13730}
}RIS
TY - JOUR
TI - Acquired and intrinsic resistance to vemurafenib in
<scp>
BRAF
<sup>V600E</sup>
</scp>
‐driven melanoma brain metastases
AU - Ping Zhang
AU - Laura Esmee Kuil
AU - Levi Conrad Maria Buil
AU - Stephan Freriks
AU - Jos Hendrik Beijnen
AU - Olaf van Tellingen
AU - Mark Cornelis de Gooijer
PY - 2023
JO - FEBS Open Bio
DO - 10.1002/2211-5463.13730
UR - https://doi.org/10.1002/2211-5463.13730
ER - APA
Zhang, P., Kuil, L. E., Buil, L. C. M., Freriks, S., Beijnen, J. H., Tellingen, O. V., & Gooijer, M. C. D. (2023). Acquired and intrinsic resistance to vemurafenib in <scp> BRAF <sup>V600E</sup> </scp> ‐driven melanoma brain metastases. FEBS Open Bio. https://doi.org/10.1002/2211-5463.13730
Source records
- crossref · retrieved 2026-09-26T17:08:40.976Z